2023 Speaking Faculty
The FULL speaking faculty for this event has not yet been announced. Please check back in the coming days for updates or join our mailing list.
CHAIR: Mark Johnston, MD, FRCPCChief Executive Officer & Medical Director
Centricity Research
Joshua Woolley, MD, Ph.D.Associate Professor, Psychiatry
UCSF Weill Institute for Neurosciences
Gul Dolen, MD, Ph.D.Associate Professor of Neuroscience, Brain Institute, Wendy Klag Center
Johns Hopkins University
Jaspreet GrewalChief Executive Officer & Co-Founder
Knowde Group
Tim SchlidtCo-founder & Partner
Palo Santo
Boris Heifets, MD, Ph.D.Assistant Professor of Anesthesiology, Perioperative & Pain Medicine
Stanford University
Bryan Roth, MD, Ph.D.Michael Hooker Distinguished Prof., Pharmacology, Dir., NIMH Psychoactive Drug Screening Program, Eshelman School of Pharmacy
Univ. of North Carolina Chapel Hill
Christopher KoddermannCo-Founder & Chair of the Board
International Therapeutics Psilocybin Rescheduling Initiative
Founder & Managing Director
CURA Communications
Natalie Gukasyan, MDAssistant Prof., Dept. of Psychiatry & Behavioral Sciences, Medical Dir., Center for Psychedelic & Consciousness Research
Johns Hopkins University School of Medicine
James Kuo, MD, MBAVice President of R&D
Silo Pharma
Sabrina Ramkellawan, CCRP, CCRAChief Operating Officer & Co-Founder
Knowde Group
Natasha Sumner, JDSenior Counsel
Husch Blackwell
Kimberly Chew, JDSenior Counsel
Husch Blackwell
Tom McDonaldChief Executive Officer
Clerkenwell Health
Manesh GirnPhD Candidate (Neuroscience), Laboratory of Brain and Cognition, Montreal Neurological Institute
McGill University
Matthew Baggott, Ph.D.Co-founder & Chief Executive Officer
Tactogen
Laszlo Kiss, Ph.D.CBO and Head of Research
Gilgamesh Pharmaceuticals
Sandeep Nayak, MDAssistant Professor, Department of Psychiatry & Behavioral Sciences, Behavioral Pharmacology Research Unit
Johns Hopkins Center for Psychedelic and Consciousness Research
Karen Luong, JDSenior Counsel
Husch Blackwell
Elliot Marseille, DrPH, MPPDirector
UC Berkeley/UCSF Global Initiative for Psychedelic Science Economics
Principal
Health Strategies International
Hailey Gilmore, MPHMedical Affairs Program Manager
MAPS Public Benefit Corporation
Graham Pechenik, JDFounder, Patent Attorney
Calyx Law
Christine Moore, Ph.D.VP, Neuroscience, Scientific Solutions
Worldwide Clinical Trials
Anton Avanceña, Ph.D.Assistant Professor of Health Outcomes
University of Texas at Austin College of Pharmacy
James LanthierChief Executive Officer
Mindset Pharma
Clare KnightSenior Clinical Trials Manager
Clerkenwell Health
Harpreet Kaur, Ph.D.Vice President of Research
PharmAla Biotech
Brett WatersCo-Founder & Executive Director
Reason for Hope
Associate Attorney
Winston & Strawn
Charlotte Smith, Ph.D.Associate Professor in Management and Organisation, School of Business
University of Leicester
Matthew ZornPartner
Yetter Coleman
Benjamin LightburnCEO & Co-Founder
Filament Health
Gisele Fernandes-Osterhold, MFTDirector of Psychedelic Facilitation, Translational Psychedelic Research Program (TrPR), BAND Lab
University of California San Francisco
Shahin ShamsData Curator
Porta Sophia
Greg DwuletPatent Agent
Calyx Law
Matias SerebrinskyCo-Founder
Psymed Ventures
Max VargasPh.D. Candidate, Neuroscience Graduate Program
University of California, Davis
The FULL speaking faculty for this event has not yet been announced. Please check back in the coming days for updates or join our mailing list.
